Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243813 · ClinicalTrials.gov registry record · Phase 1
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02243813: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT02243813 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243813, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders.
Interventions
- DRUG Psilocybin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-03 |
| Est. Completion | 2024-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02243813
The ClinicalTrials.gov registry entry for NCT02243813 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Psilocybin is the first listed.
NCT02243813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02243813 about?
NCT02243813 is a clinical study titled "Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion". The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders.
What is the current status of trial NCT02243813?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2015-03. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT02243813?
The interventions under investigation include: Psilocybin (DRUG).
Who is sponsoring clinical trial NCT02243813?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.